A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: PROCEDURE: Cryoablation|DRUG: Ipilimumab|DRUG: Nivolumab
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Bristol-Myers Squibb